Vertex Pharmaceuticals
VRTX
VRTX
1,549 hedge funds and large institutions have $95.6B invested in Vertex Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 198 funds opening new positions, 551 increasing their positions, 612 reducing their positions, and 155 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more funds holding
Funds holding: →
10% less repeat investments, than reductions
Existing positions increased: 551 | Existing positions reduced: 612
12% less capital invested
Capital invested by funds: $109B → $95.6B (-$13.3B)
45% less funds holding in top 10
Funds holding in top 10: 29 → 16 (-13)
Holders
1,549
Holding in Top 10
16
Calls
$780M
Puts
$700M
Top Buyers
| 1 | +$731M | |
| 2 | +$610M | |
| 3 | +$575M | |
| 4 |
Edgewood Management
Greenwich,
Connecticut
|
+$568M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$450M |
Top Sellers
| 1 | -$1.39B | |
| 2 | -$526M | |
| 3 | -$496M | |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$249M |
| 5 |
JP Morgan Chase
New York
|
-$248M |